Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 15:13:106.
doi: 10.3389/fnbeh.2019.00106. eCollection 2019.

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study

Maya Kritchman  1   2 , May Koubi  1   3 , Aviva Mimouni Bloch  2   4 , Yuval Bloch  1   2   3
Affiliations

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study

Maya Kritchman et al. Front Behav Neurosci. .

Abstract

Introduction: Non-adherence to efficacious pharmacotherapy is a major obstacle in the treatment of children suffering from attention deficit hyperactive disorder (ADHD). Some hold the position that pharmacotherapy induces anxiety, and that this is one of the reasons for this non-adherence. Previous studies have pointed to the opposite, a moderating effect of methylphenidate (MPH) on state anxiety in patients with ADHD. This has been shown in continuous treatment in children, but not on a single dose. We hypothesized that a single dose might have a different effect. Method: Twenty children with ADHD were given single doses of MPH in a randomized, controlled, crossover, double blind study. State anxiety using The Spielberger State-Trait Anxiety Inventory (STAI) and a continuous performance test were assessed. Results: As a group, no change was detected in state anxiety with MPH or placebo. However, children who were given MPH during the first session as opposed to those who received placebo first, demonstrated deterioration in baseline state anxiety in the second session [t (2.485), p < 0.05]. Conclusion: Our findings show a possible delayed anxiety-provoking effect of a single dose of MPH. This may be relevant to the understanding of difficulties in adherence with MPH treatment in children with ADHD. Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT01798459.

Keywords: ADHD; attention-deficit hyperactivity disorder; methylphenidate; pharmacotherapy; state anxiety.

PubMed Disclaimer

References

    1. Atkinson M., Hollis C. (2010). NICE guideline: attention deficit hyperactivity disorder. Arch. Dis. Child. Educ. Pract. Ed. 95, 24–27. 10.1136/adc.2009.175943 - DOI - PubMed
    1. Bloch Y., Aviram S., Segev A., Nitzan U., Levkovitz Y., Braw Y., et al. . (2017). Methylphenidate reduces state anxiety during a continuous performance test that distinguishes adult ADHD patients from controls. J. Atten. Disord. 21, 46–51. 10.1177/1087054712474949 - DOI - PubMed
    1. Bussing R., Fernandez M., Harwood M., Wei H, Garvan C. W., Eyberg S. M., et al. . (2008). Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment 15, 317–328. 10.1177/1073191107313888 - DOI - PMC - PubMed
    1. Chang Z., Quinn P. D., Hur K., Gibbons R. D., Sjölander A., Larsson H., et al. . (2017). Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 74, 597–603. 10.1001/jamapsychiatry.2017.0659 - DOI - PMC - PubMed
    1. Coughlin C. G., Cohen S. C., Mulqueen J. M., Ferracioli-Oda E., Stuckelman Z. D., Bloch M. H. (2015). Meta-analysis: reduced risk of anxiety with psychostimulant treatment in children with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 25, 611–617. 10.1089/cap.2015.0075 - DOI - PMC - PubMed

Associated data